Evoke Pharma Inc (EVOK)
4.50
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 13:01
Evoke Pharma Price: 4.50 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 4.58 | 4.60 | 4.50 | 4.50 | 29712.00 |
| Nov 20, 2024 | 4.70 | 4.70 | 4.504 | 4.56 | 10663.00 |
| Nov 19, 2024 | 4.28 | 4.794 | 4.28 | 4.70 | 154044.0 |
| Nov 18, 2024 | 4.58 | 4.65 | 4.35 | 4.37 | 12119.00 |
| Nov 15, 2024 | 4.40 | 4.58 | 4.365 | 4.58 | 48752.00 |
| Nov 14, 2024 | 4.29 | 4.59 | 4.29 | 4.366 | 51841.00 |
| Nov 13, 2024 | 4.80 | 5.02 | 4.03 | 4.26 | 177445.0 |
| Nov 12, 2024 | 5.30 | 5.50 | 4.90 | 5.00 | 74669.00 |
| Nov 11, 2024 | 5.59 | 5.69 | 5.30 | 5.38 | 66962.00 |
| Nov 08, 2024 | 5.87 | 5.907 | 5.54 | 5.65 | 178256.0 |
| Nov 07, 2024 | 5.67 | 5.98 | 5.56 | 5.653 | 200824.0 |
| Nov 06, 2024 | 5.90 | 6.02 | 5.64 | 5.84 | 50000.00 |
| Nov 05, 2024 | 5.58 | 6.09 | 5.31 | 5.79 | 156649.0 |
| Nov 04, 2024 | 5.70 | 6.00 | 5.304 | 5.72 | 65336.00 |
| Nov 01, 2024 | 5.97 | 6.200 | 5.80 | 5.80 | 91013.00 |
| Oct 31, 2024 | 6.58 | 6.58 | 5.66 | 5.85 | 146528.0 |
| Oct 30, 2024 | 6.19 | 6.71 | 6.08 | 6.45 | 225926.0 |
| Oct 29, 2024 | 6.43 | 6.685 | 5.72 | 6.30 | 587761.0 |
| Oct 28, 2024 | 11.11 | 12.32 | 6.83 | 7.08 | 21.13M |
| Oct 25, 2024 | 5.070 | 5.30 | 4.81 | 5.30 | 13825.00 |
| Oct 24, 2024 | 5.15 | 5.61 | 5.13 | 5.13 | 3917.00 |
| Oct 23, 2024 | 5.205 | 5.40 | 5.01 | 5.13 | 11630.00 |
| Oct 22, 2024 | 5.545 | 5.565 | 5.40 | 5.40 | 14452.00 |
| Oct 21, 2024 | 5.61 | 5.61 | 5.45 | 5.48 | 6852.00 |
| Oct 18, 2024 | 5.39 | 5.54 | 5.14 | 5.51 | 15621.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.87
Minimum
Sep 06 2024
820.80
Maximum
Aug 14 2020
147.29
Average
48.48
Median
Jan 31 2023
Price Benchmarks
| Repligen Corp | 144.35 |
| Eli Lilly and Co | 749.20 |
| MEI Pharma Inc | 2.80 |
| Revance Therapeutics Inc | 3.84 |
| NovaBay Pharmaceuticals Inc | 0.6946 |
Price Related Metrics
| PS Ratio | 0.496 |
| Price to Book Value | 1.524 |
| Earnings Yield | -245.1% |
| Market Cap | 6.687M |